Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk
Clinical trial NCT02991118 · COMPLETED
Trial details
- NCT number
- NCT02991118
- Sponsor
- Esperion Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-18
- Primary completion
- 2018-08-22
- Enrollment
- 779
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.